ImageneBio, Inc.
IMA
$8.35
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 06/30/2024 | |||
|---|---|---|---|---|---|
| Revenue | -- | 800.00K | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | 800.00K | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | 800.00K | -- | ||
| SG&A Expenses | 1.71M | 2.76M | 1.91M | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 7.36M | 6.80M | 6.39M | ||
| Operating Income | -7.36M | -6.00M | -6.39M | ||
| Income Before Tax | -7.59M | -6.08M | -6.26M | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -7.59M | -6.08M | -6.26M | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -7.59M | -6.08M | -6.26M | ||
| EBIT | -7.36M | -6.00M | -6.39M | ||
| EBITDA | -7.36M | -5.99M | -5.94M | ||
| EPS Basic | -4.46 | -0.02 | -9.21 | ||
| Normalized Basic EPS | -1.97 | -0.01 | -3.93 | ||
| EPS Diluted | -4.46 | -0.02 | -9.21 | ||
| Normalized Diluted EPS | -1.97 | -0.01 | -3.93 | ||
| Average Basic Shares Outstanding | 2.41M | 462.13M | 994.90K | ||
| Average Diluted Shares Outstanding | 2.41M | 462.13M | 994.90K | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||